# Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation

> **NCT02417870** · PHASE1,PHASE2 · TERMINATED · sponsor: **Anil K. Chandraker, MD** · enrollment: 2 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **BIOLOGICAL:** aldesleukin

## Key facts

- **NCT ID:** NCT02417870
- **Lead sponsor:** Anil K. Chandraker, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** lack of funding/resources
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417870, "Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02417870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*